| Nuclear architecture dictates HIV-1 integration site selection B Marini, A Kertesz-Farkas, H Ali, B Lucic, K Lisek, L Manganaro, ... Nature 521 (7551), 227-231, 2015 | 352 | 2015 |
| A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality M Bassetti, E Righi, F Ansaldi, M Merelli, T Cecilia, G De Pascale, ... Intensive care medicine 40, 839-845, 2014 | 295 | 2014 |
| Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain M Bassetti, M Merelli, E Righi, A Diaz-Martin, EM Rosello, R Luzzati, ... Journal of clinical microbiology 51 (12), 4167-4172, 2013 | 271 | 2013 |
| Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital R Luzzati, G Amalfitano, L Lazzarini, F Soldani, S Bellino, M Solbiati, ... European Journal of Clinical Microbiology and Infectious Diseases 19, 602-607, 2000 | 233 | 2000 |
| A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality M Bassetti, E Righi, F Ansaldi, M Merelli, C Scarparo, M Antonelli, ... Intensive care medicine 41, 1601-1610, 2015 | 223 | 2015 |
| Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project M Bassetti, DR Giacobbe, A Vena, C Trucchi, F Ansaldi, M Antonelli, ... Critical Care 23, 1-7, 2019 | 170 | 2019 |
| Transbronchial biopsy in the diagnosis of pulmonary infiltrates in immunocompromised patients A Cazzadori, G Di Perri, G Todeschini, R Luzzati, L Boschiero, G Perona, ... Chest 107 (1), 101-106, 1995 | 151 | 1995 |
| Heteroresistance to Fluconazole and Voriconazole inCryptococcus neoformans P Mondon, R Petter, G Amalfitano, R Luzzati, E Concia, I Polacheck, ... Antimicrobial Agents and Chemotherapy 43 (8), 1856-1861, 1999 | 147 | 1999 |
| Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience M Bassetti, N Castaldo, A Cattelan, C Mussini, E Righi, C Tascini, ... International journal of antimicrobial agents 53 (4), 408-415, 2019 | 139 | 2019 |
| Riboflavine and severe lactic acidosis R Luzzati, P Del Bravo, G Di Perri, A Luzzani, E Concia The Lancet 353 (9156), 901-902, 1999 | 130 | 1999 |
| Diagnosis, management and outcome of clinically-suspected spinal infection R Luzzati, D Giacomazzi, MC Danzi, L Tacconi, E Concia, S Vento Journal of Infection 58 (4), 259-265, 2009 | 118 | 2009 |
| Tick-borne encephalitis in Europe: a brief update on epidemiology, diagnosis, prevention, and treatment N Riccardi, RM Antonello, R Luzzati, J Zajkowska, S Di Bella, ... European journal of internal medicine 62, 1-6, 2019 | 117 | 2019 |
| Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study M Tumbarello, F Raffaelli, M Giannella, E Mantengoli, A Mularoni, ... Clinical Infectious Diseases 73 (9), 1664-1676, 2021 | 115 | 2021 |
| Proximity to PML nuclear bodies regulates HIV-1 latency in CD4+ T cells M Lusic, B Marini, H Ali, B Lucic, R Luzzati, M Giacca Cell host & microbe 13 (6), 665-677, 2013 | 113 | 2013 |
| Clinical reactivation of hepatitis B in anti-HBs-positive patients with AIDS. S Vento, G Di Perri, R Luzzati | 108 | 1989 |
| Impact of antibiotic changes in empirical therapy on antimicrobial resistance in intensive care unit-acquired infections B Allegranzi, R Luzzati, A Luzzani, F Girardini, L Antozzi, R Raiteri, ... Journal of Hospital Infection 52 (2), 136-140, 2002 | 104 | 2002 |
| Seroprevalence of tick-borne infections in forestry rangers from northeastern Italy M Cinco, F Barbone, MG Ciufolini, M Mascioli, MA Rosenfeld, P Stefanel, ... Clinical microbiology and infection 10 (12), 1056-1061, 2004 | 91 | 2004 |
| Clinical management of non-faecium non-faecalis vancomycin-resistant enterococci infection. Focus on Enterococcus gallinarum and Enterococcus casseliflavus/flavescens J Monticelli, A Knezevich, R Luzzati, S Di Bella Journal of Infection and Chemotherapy 24 (4), 237-246, 2018 | 90 | 2018 |
| Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2 P Manganotti, V Pesavento, A Buoite Stella, L Bonzi, E Campagnolo, ... Journal of NeuroVirology 26, 605-606, 2020 | 81 | 2020 |
| Resistance to ceftazidime/avibactam in infections and colonisations by KPC-producing Enterobacterales: a systematic review of observational clinical studies S Di Bella, DR Giacobbe, AE Maraolo, V Viaggi, R Luzzati, M Bassetti, ... Journal of Global Antimicrobial Resistance 25, 268-281, 2021 | 78 | 2021 |
mario crucianiVerifierad e-postadress på virgilio.it
mario crucianiVerifierad e-postadress på virgilio.it